Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene

European Journal of Neurology

Volumn 14, Issue 12, 2007, Pages 1344-1350

  Verny, C ^a,b   Allain, P ^a,c   Prudean, A ^a   Malinge, M C ^a   Gohier, B ^a   Scherer, C ^a   Bonneau, D ^a,d   Dubas, F ^a   Le Gall, D ^a,c  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b Huntington French Speaking Group   (France)

^c UNIVERSITÉ D'ANGERS   (France)

^d INSERM   (France)

Author keywords

Asymptomatic gene carriers; Cognitive impairment; Huntington disease

Indexed keywords

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOMOTOR DEVELOPMENT; VERBAL MEMORY;

ADOLESCENT; ADULT; AGE FACTORS; CHROMOSOMES, HUMAN, PAIR 4; COGNITION DISORDERS; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; EARLY DIAGNOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HETEROZYGOTE; HUMANS; HUNTINGTON DISEASE; MALE; MEMORY DISORDERS; MIDDLE AGED; MUTATION; NERVE TISSUE PROTEINS; NEUROPSYCHOLOGICAL TESTS; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PSYCHOMOTOR PERFORMANCE; SENSITIVITY AND SPECIFICITY;

EID: 36248977511     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.01975.x     Document Type: Article

References (37)

1. Rushton A. Genetics and Medicine in the United States 1800-1922. Baltimore: The Johns Hopkins University Press, 1994.
2. Caine ED, Fisher JM. Dementia in Huntington disease. In: Vinken PJ, Bruyn GW, Fredericks JA, eds. Neurobehavioral Disorders, Handbook of Clinical Neurology. Amsterdam: Elsevier, 1985: 305 310.
3. Siesling S, Zwinderman AH, Van Vugt JP, Kieburtz K, Roos RA. A shortened version of the motor section of the Unified Huntington's Disease Rating Scale. Movement Disorders 1997 12: 229 234.
4. Folstein SE. Huntington's Disease: a Disorder of Families. Baltimore: Johns Hopkins University Press, 1998: 1 10.
5. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993 72: 971 983.
6. Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden MR, International Huntington's Disease Collaborative Group. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clinical Genetics 2004 65: 267 277.
7. Brown RG, Marsden CD. Subcortical dementia - the neuropsychological evidence. Neuroscience 1998 25: 363 387.
8. Lawrence A, Shahakian BJ. The neuropsychology of fronto-striatal dementias. In: Woods R, ed. Handbook of the Clinical Psychology of Ageing. Wiley: Chichester, 1996: 243 265.
9. Foroud T, Siemers E, Kleindorfer D, et al. Cognitive scores in carriers of Huntington's disease gene compares to non-carriers. Annals of Neurology 1995 37: 657 664.
10. Rosenberg NK, Sorensen SA, Christensen AL. Neuropsychological characteristics of Huntington's disease carriers: a double blind study. Journal of Medical Genetics 1995 32: 600 604.
11. Hahn-Barma V, Deweer B, Dürr A, et al. Are cognitive changes the first symptoms of Huntington disease? A study of gene carriers. Journal of Neurology, Neurosurgery, and Psychiatry 1998 64: 172 177.
12. Lawrence AD, Hodges JR, Rosser A, et al. Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 1998 121: 1329 1341.
13. Snowden JS, Craufurd D, Thompson J, Neary D. Psychomotor, executive, and memory function in preclinical Huntington's disease. Journal of Clinical and Experimental Neuropsychology 2002 22: 133 145.
14. Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R. Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation: a longitudinal follow-up study. Journal of Neurology 2004 251: 935 942.
15. Farrow M, Churchyard A, Chua P, et al. Attention, inhibition, and proximity to clinical onset in preclinical mutation carriers for Huntington's disease. Journal of Clinical and Experimental Neuropsychology 2007 29: 235 246.
16. Robins-Wahlin TB, Lundin A, Dear K. Early cognitve deficits in Swedish gene carriers of Huntington's disease. Neuropsychology 2007 21: 31 44.
17. Milders M, Crawford JR, Lamb A, Simpson SA. Differential deficits in expression recognition in gene-carriers and patients with Huntington's disease. Neuropsychologia 2003 41: 1484 1492.
18. Blackmore L, Simpson SA, Crawford JR. Cognitive performance in UK sample of presymptomatic people carrying the gene for Huntington's disease. Journal of Medical Genetics 1995 32: 358 362.
19. Giordani B, Berent S, Boivin MJ, et al. Longitudinal neuropsychological and genetic linkage analysis of persons at risk for Huntington's disease. Archives of Neurology 1995 52: 59 64.
20. Campodonico JR, Codori AM, Brandt J. Neuropsychological stability over two years in asymptomatic carriers of the Huntington's disease mutation. Journal of Neurology, Neurosurgery, and Psychiatry 1996 61: 621 624.
21. De Boo GM, Tibben A, Lanser JBK, et al. Early cognitive and motor symptoms in identified carriers of the gene for Huntington's disease. Archives of Neurology 1997 54: 1353 1357.
22. Witjes-Ane MN, Vegter-Van der Vlis M, Van Vugt JP, et al. Cognitive and motor functioning in gene carriers for Huntington's disease: a baseline study. Journal of Neuropsychiatry and Clinical Neurosciences 2003 15: 7 16.
23. Brandt J, Shpritz B, Codori AM, Margolis R, Rosenblatt A. Neuropsychological manifestations of the genetic mutation for Huntington's disease in presymptomatic individuals. Journal of the International Neuropsychological Society 2002 8: 918 924.
24. Soliveri P, Monza D, Piacentini S, et al. Cognitive and psychiatric characterization of patients with Huntington's disease and their at-risk relatives. Neurological Sciences 2002 23: S105 S106.
25. West R. In defense of the frontal lobe hypothesis of cognitive aging. Journal of the International Neuropsychological Society 2000 6: 727 729.
26. Backman L, Robins-Wahlin TB, Lundin A, Ginovart N, Farde L. Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes. Brain 1997 120: 2207 2217.
27. Caine ED, Hunt RD, Weingartner H, Ebert MH. Huntington's dementia: clinical and neuropsychological features. Archives of General Psychiatry 1978 35: 377 384.
28. Butters N, Sax D, Montgomery K, Tarlow S. Comparison of the neuropsychological deficits associated with early and advanced Huntington's disease. Archives of Neurology 1978 35: 585 589.
29. Josiassen RC, Curry L, Roemer RA, DeBease C, Mancall EL. Patterns of intellectual deficit in Huntington's disease. Journal of Clinical Neuropsychology 1982 4: 173 183.
30. Brandt J, Strauss ME, Larus J, Jensen B, Folstein SE, Folstein MF. Clinical correlates of dementia and disability in Huntington's disease. Journal of Clinical Neuropsychology 1984 6: 401 412.
31. Smith S, Butters N, White R, Lyon L, Granholm E. Priming semantic relations in patients with Huntington's disease. Brain and Language 1988 33: 27 40.
32. Lange KW, Sahakian BJ, Quinn NP, Marsden CD, Robbins TW. Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia. Journal of Neurology, Neurosurgery, and Psychiatry 1995 58: 598 606.
33. Brandt J. Cognitive impairments in Huntington's disease: insights into the neuropsychology of the striatum. In: Boller F, Grafman J, eds. Handbook of Neuropsychology. New York: Elsevier, 1991: 241 264.
34. Massman PJ, Delis DC, Butters N, Levin BE, Salmon DP. Are all subcortical dementias alike? Verbal learning and memory in Parkinson's and Huntington's disease patients. Journal of Clinical and Experimental Neuropsychology 1990 12: 729 744.
35. Jason GW, Pajurkowa EM, Suchowersky O, et al. Presymptomatic neuropsychological impairment in Hintington's disease. Archives of Neurology 1988 45: 769 773.
36. Lawrence AD, Sahakian BJ, Hodges JR, et al. Executive and mnemonic functions in early Huntington's disease. Brain 1996 199: 1633 1645.
37. Chevalier G, Deniau JM. Desinhibition as a basic process in the expression of striatal functions. Trends in Neurosciences 1990 13: 277 280.